with 5 CFR 1320, the information collection is approved. However,
the agency must submit a final version of the instrument (as it
will be fielded) prior to beginning the study.
Inventory as of this Action
36 Months From Approved
This project will investigate the
effects of adding disease information to branded prescription drug
promotional materials on consumer perceptions and understanding.
Part of FDA's public health mission is to ensure the safe use of
prescription drugs; therefore it is important to communicate the
risks and benefits of prescription drugs to consumers in a way that
is clear, useful and non-misleading. The results from this project
will be used by FDA to inform its understanding of DTC advertising,
inform regulatory policy, and may also help to identify areas for